@FierceBiotech: Celsion shares routed after PhIII liver cancer study flops. News | Follow @FierceBiotech
@JohnCFierce: AstraZeneca's Soriot is going to have to do something bold, something dramatic, and something a little loony. In that order. | Follow @JohnCFierce
@RyanMFierce: Holland's health minister is sounding very German on drug pricing, wants to chop cost of Genzyme and Shire therapies. More | Follow @RyanMFierce
> Teva ($TEVA) has axed a cancer drug partnership with Israel's CureTech. Teva took a $109 million charge after deciding to drop the deal with CureTech on CT-011. The decision followed an analysis of clinical and biochemical data. Report
> AC Immune has slammed the brakes on one of its Alzheimer's programs. ACI-91, which was in-licensed, failed a small Phase II study for mild to moderate Alzheimer's. Far from improving measures of cognition and clinical function, patients demonstrated a drop on both scores. Release
> The U.K.'s BioIndustry Association is highlighting a new survey on the public's support for crowdfunding, which not coincidentally comes as the association is calling for government support for the initiative. Story
Pharma News
@FiercePharma: EMA sounds a bit perturbed about France's suspension of Diane-35. But it will review data when France asks. More | Follow @FiercePharma
@AlisonBFierce: Life Technologies established an international flu network to develop a speedy monitoring system and better vaccine. News | Follow @AlisonBFierce
@EricPFierce: BASF says it has finally gotten the Pronova deal closed making it one of the largest fish oil producers in the world. Release | Follow @EricPFierce
> Novo meets 'sky-high' expectations with 18% sales growth. Report
> Genzyme's $176K Kynamro price undercuts its $250K-plus rival. Article
> Patent Cliff II: Nightmare on blockbuster street returns in 2015. News
Vaccines News
> MIT explores DNA vaccine delivery. Item
> Life establishes international flu network. More
> CDC: Adult vaccination rates 'unacceptably low.' Report
> FDA expands use of Pfizer's Prevnar 13. Article
> GSK, Biological E partner on childhood vaccine. Story
Pharma Manufacturing News
> Cargo theft up dramatically in Mexico. Item
> Sanofi's Genzyme looking hard at continuous manufacturing. News
> Biogen, Merck, Novartis, others have plants recognized for innovations. More
> Teva, P&G start on OTC plant in India. Story
And Finally… Star Scientific says that its experimental therapy anatabine looked promising in an animal model of multiple sclerosis. Release